別品名 |
Antibacterial protein LL-37, Cathelicidin antimicrobial peptide CAP18; CRAMP; FALL-39; FALL39;- CAP-18; hCAP-18; HSD26
|
種由来 |
Human
|
標識物 |
Unlabeled
|
精製度 |
Affinity Purified
|
適用 |
Western Blot IHC paraffin embedding section Immuno Fluorescence Immuno Assay
|
免疫動物 |
Mouse
|
抗体クラス |
IgG2a
|
クローン |
1-1C12
|
形状 |
溶液
|
参考文献 |
1. Felgentreff, K et al; The antimicrobial peptide cathelicidin interacts with airway mucus. Peptides 2006, 27: 3100 2. Bucki, R et al; Salivary mucins inhibit antibacterial activity of the cathelicidin-derived LL-37 peptide but not the cationic steroid CSA-13. J Antimicrob Chemother 2008, 62: 329 3. Dick, E et al; Ex vivo-expanded bone marrow CD34+ derived neutrophils have limited bactericidal ability. Stem Cells 2008, 26: 2552 4. Von Haussen, L et al; The host defence peptide LL-37/hCAP18 is a growth factor for lung cancer cells. Lung Canc 2008, 59: 12 5. Kockritz-Blickwede, M et al. Phagocytosis-independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 2008. 111(6): 3070 6. Coffelt, SB. Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion. Int J Cancer 2008. 122: 1030-1039
|
※サムネイル画像をクリックすると拡大画像が表示されます。
|
|
|
メーカー |
品番 |
包装 |
HCB
|
HM2071-20UG
|
20 UG
|
※表示価格について
当社在庫 |
なし
|
納期目安 |
2週間程度
|
保存温度 |
4℃
|
|